US medical device company Visioneering Technologies (VTI) has teamed up with Australia’s Gelflex to distribute its NaturalVue (etafilcon A) Multifocal 1 Day contact lenses across Australia and New Zealand (ANZ).
Supplying nearly two-thirds of eye care professionals across the Australia, Gelflex is considered one of the region’s largest distributors of optical products in the ANZ region. The company officially began distributing NaturalVue Multifocal from 19 August, 2024.
Dr Juan Carlos Aragon, CEO of the ASX-listed VTI, said: “Gelflex is one of the best-known manufacturers and distributors of contact lenses in the Asia-Pacific region.
“Their focus on providing products that enhance patient health and support strong practices are the attributes that attracted VTI to the company and we believe Gelflex is well-positioned to support our growth strategies across the region.”
Gelflex managing director Mr David Masel said he was “thrilled to provide our customers with the VTI portfolio of products”.
“The unique extended depth-of-focus design of the NaturalVue Multifocal provides eyecare practitioners the ability to serve a wide range of patient types – from progressing myopes to advanced presbyopia – all with one lens,” he said.
“The product has been well received by practitioners and fits in perfectly with our suite of offerings. Our goal is to provide products, services, and tools that drive growth and profitability among practitioners.”
More reading
Visioneering Technologies opens myopia control contact lens to Australian market
Visioneering Technologies targets $11.1 million in new financing
Contact Lens Company set for ASX listing
